These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 19070640)
1. Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01. Iyer AV; Pahar B; Boudreaux MJ; Wakamatsu N; Roy AF; Chouljenko VN; Baghian A; Apetrei C; Marx PA; Kousoulas KG Vaccine; 2009 Feb; 27(6):893-903. PubMed ID: 19070640 [TBL] [Abstract][Full Text] [Related]
2. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge. De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens. Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903 [TBL] [Abstract][Full Text] [Related]
4. Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus. Zhu B; Ye J; Lu P; Jiang R; Yang X; Fu ZF; Chen H; Cao S Virol J; 2012 Jul; 9():132. PubMed ID: 22799608 [TBL] [Abstract][Full Text] [Related]
5. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses. Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007 [TBL] [Abstract][Full Text] [Related]
6. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880 [TBL] [Abstract][Full Text] [Related]
7. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice. Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682 [TBL] [Abstract][Full Text] [Related]
8. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050 [TBL] [Abstract][Full Text] [Related]
9. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075 [TBL] [Abstract][Full Text] [Related]
10. A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice. Pinto AK; Richner JM; Poore EA; Patil PP; Amanna IJ; Slifka MK; Diamond MS J Virol; 2013 Feb; 87(4):1926-36. PubMed ID: 23221549 [TBL] [Abstract][Full Text] [Related]
11. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. Chu JH; Chiang CC; Ng ML J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111 [TBL] [Abstract][Full Text] [Related]
12. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098 [TBL] [Abstract][Full Text] [Related]
13. Towards the conservation of endangered avian species: a recombinant West Nile Virus vaccine results in increased humoral and cellular immune responses in Japanese Quail (Coturnix japonica). Young JA; Jefferies W PLoS One; 2013; 8(6):e67137. PubMed ID: 23825633 [TBL] [Abstract][Full Text] [Related]
14. Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection. Lauretti F; Chattopadhyay A; de Oliveira França RF; Castro-Jorge L; Rose J; Fonseca BA Hum Vaccin Immunother; 2016 Sep; 12(9):2327-33. PubMed ID: 27185081 [TBL] [Abstract][Full Text] [Related]
15. Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis. Uhrlaub JL; Brien JD; Widman DG; Mason PW; Nikolich-Zugich J J Immunol; 2011 Apr; 186(7):3882-91. PubMed ID: 21339368 [TBL] [Abstract][Full Text] [Related]
16. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice. Venter M; van Vuren PJ; Mentoor J; Paweska J; Williams J Vaccine; 2013 Aug; 31(37):3856-62. PubMed ID: 23820079 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Lieberman MM; Nerurkar VR; Luo H; Cropp B; Carrion R; de la Garza M; Coller BA; Clements D; Ogata S; Wong T; Martyak T; Weeks-Levy C Clin Vaccine Immunol; 2009 Sep; 16(9):1332-7. PubMed ID: 19641099 [TBL] [Abstract][Full Text] [Related]
18. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Martina BE; Koraka P; van den Doel P; van Amerongen G; Rimmelzwaan GF; Osterhaus AD Vaccine; 2008 Jan; 26(2):153-7. PubMed ID: 18069096 [TBL] [Abstract][Full Text] [Related]
19. Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses. Schepp-Berglind J; Luo M; Wang D; Wicker JA; Raja NU; Hoel BD; Holman DH; Barrett AD; Dong JY Clin Vaccine Immunol; 2007 Sep; 14(9):1117-26. PubMed ID: 17634508 [TBL] [Abstract][Full Text] [Related]
20. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE). Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]